ARQiv-HTS, a versatile whole-organism screening platform enabling in vivo drug discovery at high-throughput rates
Authors:
- 10 November 2016
- journal article
- research article
- Published by Springer Nature in Nature Protocols
- Vol. 11 (12) , 2432-2453
Abstract
White et al. present a protocol for ARQiv-HTS, a high-throughput reporter-based screening platform that can be used to examine the effects of chemical compound libraries on zebrafish in vivo. The zebrafish has emerged as an important model for whole-organism small-molecule screening. However, most zebrafish-based chemical screens have achieved only mid-throughput rates. Here we describe a versatile whole-organism drug discovery platform that can achieve true high-throughput screening (HTS) capacities. This system combines our automated reporter quantification in vivo (ARQiv) system with customized robotics, and is termed 'ARQiv-HTS'. We detail the process of establishing and implementing ARQiv-HTS: (i) assay design and optimization, (ii) calculation of sample size and hit criteria, (iii) large-scale egg production, (iv) automated compound titration, (v) dispensing of embryos into microtiter plates, and (vi) reporter quantification. We also outline what we see as best practice strategies for leveraging the power of ARQiv-HTS for zebrafish-based drug discovery, and address technical challenges of applying zebrafish to large-scale chemical screens. Finally, we provide a detailed protocol for a recently completed inaugural ARQiv-HTS effort, which involved the identification of compounds that elevate insulin reporter activity. Compounds that increased the number of insulin-producing pancreatic beta cells represent potential new therapeutics for diabetic patients. For this effort, individual screening sessions took 1 week to conclude, and sessions were performed iteratively approximately every other day to increase throughput. At the conclusion of the screen, more than a half million drug-treated larvae had been evaluated. Beyond this initial example, however, the ARQiv-HTS platform is adaptable to almost any reporter-based assay designed to evaluate the effects of chemical compounds in living small-animal models. ARQiv-HTS thus enables large-scale whole-organism drug discovery for a variety of model species and from numerous disease-oriented perspectives.Keywords
This publication has 49 references indexed in Scilit:
- An Ultra High-Throughput, Whole-Animal Screen for Small Molecule Modulators of a Specific Genetic Pathway in Caenorhabditis elegansPLOS ONE, 2013
- Interference with xenobiotic metabolic activity by the commonly used vehicle solvents dimethylsulfoxide and methanol in zebrafish (Danio rerio) larvae but not Daphnia magnaChemosphere, 2012
- Chemical screen identifies FDA-approved drugs and target pathways that induce precocious pancreatic endocrine differentiationProceedings of the National Academy of Sciences, 2011
- Rapid behavior-based identification of neuroactive small molecules in the zebrafishNature Chemical Biology, 2010
- Chemical modifier screen identifies HDAC inhibitors as suppressors of PKD modelsProceedings of the National Academy of Sciences, 2009
- Notch-responsive cells initiate the secondary transition in larval zebrafish pancreasMechanisms of Development, 2009
- Zebrafish chemical screening reveals an inhibitor of Dusp6 that expands cardiac cell lineagesNature Chemical Biology, 2009
- Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasisNature, 2007
- Chemical genetics suggests a critical role for lysyl oxidase in zebrafish notochord morphogenesisMolecular BioSystems, 2006
- Quantitative high-throughput screening: A titration-based approach that efficiently identifies biological activities in large chemical librariesProceedings of the National Academy of Sciences, 2006